CD34 and angina pectoris: Additionally, growing data from clinical trials [38], including our recent study [39], have shown that both circulatory derived and bone marrow derived CD34+ stem cell therapy remarkably improved angina and ischemia-related left ventricular dysfunction, and restored the microvascular blood flow.